Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jennifer Kiser

Concepts (348)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antiviral Agents
30
2023
645
6.440
Why?
Anti-HIV Agents
32
2023
666
4.540
Why?
HIV Infections
53
2023
2469
4.450
Why?
Hepatitis C
13
2023
219
4.410
Why?
Adenine
27
2022
219
4.020
Why?
Hepatitis C, Chronic
13
2023
151
3.910
Why?
Ribavirin
15
2020
89
3.910
Why?
Sofosbuvir
12
2023
54
3.610
Why?
Drug Interactions
21
2019
338
3.450
Why?
Tenofovir
28
2022
204
3.030
Why?
Tandem Mass Spectrometry
16
2023
411
2.480
Why?
Hepacivirus
10
2023
229
1.990
Why?
Proline
5
2019
72
1.960
Why?
Oligopeptides
8
2015
236
1.870
Why?
Dried Blood Spot Testing
12
2023
71
1.780
Why?
Organophosphates
13
2022
90
1.760
Why?
Organophosphonates
12
2014
90
1.630
Why?
Ritonavir
8
2021
71
1.500
Why?
Protease Inhibitors
4
2020
97
1.450
Why?
Emtricitabine
17
2021
147
1.390
Why?
Chromatography, Liquid
13
2023
347
1.330
Why?
Phosphorous Acids
3
2019
12
1.240
Why?
Benzimidazoles
5
2020
138
1.230
Why?
Coinfection
4
2018
120
1.160
Why?
Fluorenes
4
2020
38
1.140
Why?
Pyrophosphatases
3
2016
22
1.120
Why?
Nucleotides
3
2016
112
1.100
Why?
Medication Adherence
16
2022
536
1.010
Why?
Anti-Retroviral Agents
5
2019
207
0.980
Why?
Drug Therapy, Combination
11
2018
951
0.900
Why?
Hepatitis B
3
2022
51
0.880
Why?
Pyridines
5
2015
425
0.880
Why?
Erythrocytes
8
2016
591
0.840
Why?
Humans
96
2023
114654
0.840
Why?
Polyphosphates
7
2022
33
0.810
Why?
Cell Phone
1
2022
76
0.780
Why?
Reverse Transcriptase Inhibitors
5
2014
82
0.770
Why?
HIV Protease Inhibitors
5
2011
64
0.770
Why?
HIV-1
7
2021
768
0.760
Why?
Membrane Transport Proteins
4
2016
138
0.750
Why?
Sulfonamides
5
2019
445
0.740
Why?
Simeprevir
2
2018
8
0.740
Why?
Mobile Applications
1
2022
141
0.720
Why?
Therapies, Investigational
1
2019
14
0.680
Why?
Respiratory Syncytial Virus Infections
1
2020
97
0.650
Why?
Heterocyclic Compounds, 3-Ring
2
2023
28
0.640
Why?
Male
51
2023
55579
0.640
Why?
Ethanol
1
2023
538
0.630
Why?
Adult
40
2021
30542
0.630
Why?
Middle Aged
35
2020
26732
0.620
Why?
Lung Transplantation
1
2020
246
0.610
Why?
Pyridazines
2
2021
46
0.600
Why?
Antiretroviral Therapy, Highly Active
4
2015
256
0.590
Why?
Liver
2
2016
1637
0.580
Why?
Solid Phase Extraction
2
2014
20
0.580
Why?
Leukocytes, Mononuclear
8
2021
493
0.580
Why?
Pyrimidinones
2
2008
88
0.560
Why?
Viral Load
10
2023
405
0.560
Why?
HIV Integrase Inhibitors
1
2018
62
0.550
Why?
Inosine
1
2016
11
0.550
Why?
Guanosine
1
2016
39
0.540
Why?
Pharmacogenomic Variants
1
2016
33
0.530
Why?
Female
45
2023
59488
0.520
Why?
Chromatography, High Pressure Liquid
2
2015
470
0.520
Why?
Purines
1
2016
159
0.510
Why?
Kidney
4
2016
1188
0.500
Why?
Drug Monitoring
3
2022
184
0.500
Why?
Drug Discovery
1
2016
123
0.500
Why?
Isoniazid
2
2012
52
0.490
Why?
Serum
1
2015
57
0.480
Why?
Adenosine
1
2016
203
0.480
Why?
Intracellular Space
1
2014
68
0.470
Why?
Telemedicine
1
2022
662
0.470
Why?
Pre-Exposure Prophylaxis
5
2020
179
0.460
Why?
HIV
4
2019
208
0.450
Why?
Antitubercular Agents
2
2012
169
0.450
Why?
Deoxycytidine
6
2017
138
0.450
Why?
Receptors, Adrenergic, alpha
1
2013
28
0.440
Why?
Priapism
1
2013
10
0.440
Why?
Adrenergic alpha-Antagonists
1
2013
29
0.440
Why?
Cytochrome P-450 CYP3A Inhibitors
1
2013
18
0.440
Why?
Gastric Bypass
1
2014
92
0.410
Why?
Hepatitis B, Chronic
3
2022
18
0.410
Why?
Treatment Outcome
12
2021
9087
0.410
Why?
Prospective Studies
17
2022
6217
0.390
Why?
Phenotype
2
2016
2796
0.390
Why?
Pyrimidines
3
2021
376
0.370
Why?
HIV Seronegativity
1
2010
24
0.360
Why?
Genotype
6
2023
1760
0.360
Why?
Antacids
1
2010
15
0.360
Why?
Pyrrolidinones
1
2010
25
0.360
Why?
Patient Compliance
3
2017
525
0.350
Why?
Hepatitis B virus
3
2022
25
0.350
Why?
Tuberculosis
2
2012
241
0.350
Why?
Pharmacy Service, Hospital
1
2011
83
0.350
Why?
Reproducibility of Results
8
2016
2762
0.340
Why?
Blood Chemical Analysis
4
2019
90
0.330
Why?
Plasma
4
2016
211
0.330
Why?
Area Under Curve
4
2018
274
0.330
Why?
Adolescent
19
2020
17837
0.320
Why?
Uridine Monophosphate
2
2019
15
0.320
Why?
Drug Prescriptions
1
2011
239
0.320
Why?
Young Adult
16
2020
10465
0.310
Why?
Fluorobenzenes
1
2008
11
0.310
Why?
Drug Stability
5
2016
151
0.300
Why?
Guidelines as Topic
1
2009
243
0.290
Why?
Liver Transplantation
1
2014
707
0.290
Why?
Sensitivity and Specificity
5
2014
1691
0.280
Why?
Atazanavir Sulfate
5
2015
41
0.280
Why?
Half-Life
3
2015
141
0.270
Why?
Glycerophospholipids
2
2023
26
0.270
Why?
Alanine
3
2021
104
0.270
Why?
Esomeprazole
1
2006
6
0.270
Why?
Anti-Ulcer Agents
1
2006
16
0.260
Why?
Pharmacology, Clinical
1
2006
8
0.260
Why?
Carbamates
1
2006
34
0.260
Why?
Sustained Virologic Response
3
2023
33
0.260
Why?
Hepatocytes
3
2016
195
0.260
Why?
Education
1
2006
95
0.250
Why?
Biomarkers
5
2023
3408
0.250
Why?
Proton Pump Inhibitors
1
2006
96
0.240
Why?
South Africa
4
2015
161
0.240
Why?
Phosphates
3
2015
159
0.230
Why?
Anemia
2
2016
143
0.230
Why?
Health Personnel
1
2009
574
0.220
Why?
Variola virus
1
2022
1
0.210
Why?
Smallpox
1
2022
7
0.210
Why?
Delivery of Health Care
1
2009
833
0.200
Why?
Cross-Over Studies
4
2020
440
0.200
Why?
World Health Organization
1
2022
102
0.200
Why?
Linear Models
2
2014
768
0.190
Why?
Cyclopropanes
2
2019
81
0.190
Why?
Point-of-Care Systems
1
2023
136
0.190
Why?
Lopinavir
3
2020
29
0.190
Why?
Dideoxynucleosides
2
2023
20
0.190
Why?
Interferons
2
2019
151
0.180
Why?
Phosphorylation
2
2015
1569
0.180
Why?
Aminoisobutyric Acids
1
2019
7
0.170
Why?
Drug Administration Schedule
3
2019
718
0.170
Why?
Lactams, Macrocyclic
1
2019
46
0.170
Why?
Pyrrolidines
1
2019
55
0.160
Why?
Homosexuality, Male
2
2017
170
0.160
Why?
Quinoxalines
1
2019
60
0.160
Why?
Leucine
1
2019
102
0.160
Why?
Nucleic Acids
1
2019
59
0.160
Why?
Pregnancy Complications, Infectious
2
2020
288
0.160
Why?
Quality Control
2
2015
144
0.150
Why?
Bronchoalveolar Lavage Fluid
1
2020
590
0.150
Why?
Organic Anion Transport Protein 1
2
2008
6
0.150
Why?
Oxazines
1
2018
25
0.150
Why?
Multidrug Resistance-Associated Proteins
2
2008
34
0.150
Why?
Liver Cirrhosis
1
2019
227
0.150
Why?
Directly Observed Therapy
1
2017
14
0.150
Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2017
14
0.150
Why?
Pregnancy Outcome
1
2020
337
0.150
Why?
Nitriles
2
2021
149
0.140
Why?
Pharmacogenetics
2
2016
149
0.140
Why?
Inosine Triphosphate
1
2016
3
0.140
Why?
Molecular Targeted Therapy
1
2019
347
0.140
Why?
Anemia, Hemolytic
1
2016
18
0.140
Why?
Darunavir
2
2014
17
0.140
Why?
Zika Virus
1
2017
61
0.140
Why?
Deoxyadenine Nucleotides
1
2016
13
0.140
Why?
Deoxycytosine Nucleotides
1
2016
11
0.140
Why?
Pharmacy
1
2017
28
0.140
Why?
Pyridones
1
2018
123
0.140
Why?
Guanosine Triphosphate
1
2016
85
0.140
Why?
Glass
1
2016
42
0.140
Why?
Genitalia
1
2016
28
0.130
Why?
Retrospective Studies
4
2020
12544
0.130
Why?
Disease Transmission, Infectious
1
2017
55
0.130
Why?
Syringes
1
2016
41
0.130
Why?
Viremia
3
2022
122
0.130
Why?
Drug Packaging
1
2016
42
0.130
Why?
Drug and Narcotic Control
1
2016
29
0.130
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2011
373
0.130
Why?
Polymers
1
2019
448
0.130
Why?
Fibroblast Growth Factors
2
2014
162
0.130
Why?
Mental Health Services
1
2019
317
0.130
Why?
Practice Guidelines as Topic
2
2016
1394
0.130
Why?
Polymorphism, Single Nucleotide
2
2016
1879
0.130
Why?
Creatinine
2
2018
425
0.130
Why?
Piperazines
1
2018
309
0.130
Why?
Analgesics
1
2017
158
0.130
Why?
Rectum
1
2016
153
0.120
Why?
Biological Assay
1
2016
112
0.120
Why?
Cytosol
1
2016
208
0.120
Why?
Virus Replication
1
2017
395
0.120
Why?
Brain Diseases
1
2016
124
0.120
Why?
Population
1
2015
28
0.120
Why?
Nonlinear Dynamics
1
2015
83
0.120
Why?
Chemical and Drug Induced Liver Injury
1
2016
125
0.120
Why?
Infant
5
2020
7959
0.120
Why?
Liver Function Tests
1
2015
103
0.120
Why?
Pharmacists
1
2017
233
0.120
Why?
CD4 Lymphocyte Count
2
2015
257
0.120
Why?
Adenosine Triphosphate
1
2016
430
0.120
Why?
Administration, Oral
3
2019
728
0.120
Why?
Pharmaceutical Preparations
1
2016
165
0.110
Why?
Least-Squares Analysis
1
2014
70
0.110
Why?
Double-Blind Method
3
2013
1660
0.110
Why?
Metabolic Clearance Rate
2
2018
102
0.110
Why?
Hypophosphatemia
1
2013
15
0.110
Why?
Cholecalciferol
1
2014
47
0.110
Why?
Liver Diseases
1
2016
255
0.110
Why?
Diphosphates
3
2021
16
0.110
Why?
Calcitriol
1
2013
53
0.110
Why?
Cytochrome P-450 CYP3A
1
2013
61
0.110
Why?
Leukocytes
1
2014
276
0.110
Why?
Tablets
2
2023
36
0.110
Why?
Child, Preschool
4
2021
9111
0.100
Why?
Desiccation
1
2012
17
0.100
Why?
Diabetes Mellitus
1
2020
900
0.100
Why?
Kidney Diseases
1
2016
350
0.100
Why?
Monocytes
1
2015
502
0.100
Why?
Benzoxazines
1
2012
28
0.100
Why?
Organic Anion Transporters
1
2011
15
0.100
Why?
Pravastatin
1
2011
28
0.100
Why?
Levonorgestrel
1
2012
31
0.100
Why?
Mental Disorders
1
2019
892
0.100
Why?
Vitamin D Deficiency
1
2013
158
0.100
Why?
Arylamine N-Acetyltransferase
1
2011
5
0.100
Why?
Specimen Handling
1
2012
155
0.090
Why?
Nucleosides
1
2011
25
0.090
Why?
Interferon-alpha
1
2012
186
0.090
Why?
Contraceptive Agents, Female
1
2012
64
0.090
Why?
Models, Statistical
1
2015
599
0.090
Why?
Patient Acceptance of Health Care
1
2017
681
0.090
Why?
Aged
4
2018
19068
0.090
Why?
Raltegravir Potassium
1
2010
16
0.090
Why?
Body Weight
1
2015
870
0.090
Why?
Hospitals, University
1
2011
172
0.090
Why?
Cohort Studies
2
2019
4895
0.090
Why?
Sex Characteristics
1
2015
640
0.090
Why?
Dietary Supplements
1
2014
460
0.090
Why?
Sex Distribution
1
2011
337
0.090
Why?
Mycobacterium tuberculosis
1
2012
268
0.080
Why?
Time Factors
4
2016
6115
0.080
Why?
Drug Combinations
2
2020
287
0.080
Why?
Lamivudine
2
2023
59
0.080
Why?
Rosuvastatin Calcium
1
2008
17
0.080
Why?
Immunosuppressive Agents
1
2012
646
0.070
Why?
Case-Control Studies
2
2020
3003
0.070
Why?
Kidney Calculi
1
2007
30
0.070
Why?
Portugal
1
2006
9
0.070
Why?
Gene Frequency
1
2008
477
0.070
Why?
Education, Medical
1
2009
215
0.070
Why?
Self Report
2
2021
696
0.070
Why?
Dementia
1
2009
187
0.070
Why?
Referral and Consultation
1
2011
632
0.070
Why?
Quebec
1
2006
5
0.070
Why?
Furans
1
2006
22
0.070
Why?
Sexual and Gender Minorities
2
2019
138
0.060
Why?
United States
4
2017
12179
0.060
Why?
Child
4
2021
18407
0.060
Why?
Internationality
1
2006
143
0.060
Why?
Infectious Disease Transmission, Vertical
2
2020
152
0.060
Why?
Hematocrit
2
2016
87
0.060
Why?
Lipids
1
2008
580
0.060
Why?
Predictive Value of Tests
2
2019
1796
0.060
Why?
Risk Assessment
1
2012
2968
0.050
Why?
Isoindoles
1
2022
4
0.050
Why?
Monkeypox virus
1
2022
12
0.050
Why?
Animals
4
2022
31698
0.050
Why?
Calibration
2
2013
125
0.050
Why?
Computer Simulation
2
2016
872
0.050
Why?
Temperature
2
2016
565
0.050
Why?
Benzamides
1
2022
169
0.050
Why?
Pregnancy
3
2020
5517
0.050
Why?
Demography
1
2022
260
0.050
Why?
Treatment Failure
1
2023
331
0.050
Why?
Tissue Donors
1
2023
316
0.040
Why?
Drug Approval
1
2020
78
0.040
Why?
Lactation
1
2020
149
0.040
Why?
Dose-Response Relationship, Drug
2
2016
1842
0.040
Why?
Benchmarking
1
2020
161
0.040
Why?
Models, Biological
2
2016
1620
0.040
Why?
Developing Countries
1
2020
235
0.040
Why?
Chemistry Techniques, Analytical
1
2018
18
0.040
Why?
Flaviviridae
1
2017
4
0.040
Why?
Drug Repositioning
1
2017
13
0.040
Why?
Hair
1
2018
65
0.040
Why?
Vero Cells
1
2017
63
0.040
Why?
A549 Cells
1
2017
51
0.040
Why?
Inhibitory Concentration 50
1
2017
74
0.040
Why?
Breast Feeding
1
2020
368
0.040
Why?
Alcohol Drinking
1
2023
651
0.040
Why?
Pharmaceutical Solutions
1
2016
14
0.030
Why?
Patient Selection
1
2020
641
0.030
Why?
Cities
1
2017
80
0.030
Why?
Chromatography, Reverse-Phase
1
2016
26
0.030
Why?
Acute Disease
1
2019
910
0.030
Why?
Drug Storage
1
2016
58
0.030
Why?
Defective Viruses
1
2016
4
0.030
Why?
Drug Compounding
1
2016
89
0.030
Why?
Clinical Trials as Topic
1
2020
931
0.030
Why?
Solubility
1
2016
223
0.030
Why?
Spermatozoa
1
2016
84
0.030
Why?
Methanol
1
2016
29
0.030
Why?
Cold Temperature
1
2016
126
0.030
Why?
Blood-Brain Barrier
1
2016
106
0.030
Why?
Solutions
1
2016
146
0.030
Why?
Pregnancy Complications
1
2020
429
0.030
Why?
Hydrogen-Ion Concentration
1
2016
511
0.030
Why?
Comorbidity
1
2019
1448
0.030
Why?
Administration, Inhalation
1
2016
641
0.030
Why?
Logistic Models
1
2020
1840
0.030
Why?
Risk-Taking
1
2017
333
0.030
Why?
Feasibility Studies
1
2017
740
0.030
Why?
Mental Health
1
2019
562
0.030
Why?
Recurrence
1
2017
935
0.030
Why?
Interleukins
1
2016
236
0.030
Why?
DNA, Viral
1
2016
350
0.030
Why?
Vitamin D-Binding Protein
1
2013
13
0.030
Why?
Algorithms
1
2020
1467
0.030
Why?
Parathyroid Hormone
1
2013
96
0.030
Why?
Water
1
2016
396
0.030
Why?
Therapeutic Equivalency
1
2012
18
0.030
Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
238
0.020
Why?
Cell Line
1
2017
2635
0.020
Why?
Alkynes
1
2012
53
0.020
Why?
Anion Exchange Resins
1
2011
7
0.020
Why?
Longitudinal Studies
1
2018
2387
0.020
Why?
Zidovudine
1
2011
77
0.020
Why?
Food-Drug Interactions
1
2010
6
0.020
Why?
Reference Standards
1
2011
159
0.020
Why?
Epithelial Cells
1
2016
950
0.020
Why?
Chemoprevention
1
2010
88
0.020
Why?
Glomerular Filtration Rate
1
2013
604
0.020
Why?
Latent Tuberculosis
1
2011
64
0.020
Why?
Haplotypes
1
2011
448
0.020
Why?
Infant, Newborn
1
2020
5044
0.020
Why?
Cholesterol
1
2011
367
0.020
Why?
Triglycerides
1
2011
467
0.020
Why?
AIDS Dementia Complex
1
2009
50
0.020
Why?
Cross-Sectional Studies
1
2019
4407
0.020
Why?
Follow-Up Studies
1
2017
4411
0.020
Why?
Polymorphism, Genetic
1
2011
610
0.020
Why?
Positron-Emission Tomography
1
2009
259
0.020
Why?
Acquired Immunodeficiency Syndrome
1
2009
217
0.020
Why?
Calcium
1
2013
1108
0.020
Why?
Gene Expression Regulation
1
2016
2319
0.020
Why?
Aged, 80 and over
1
2018
6345
0.020
Why?
Neuropsychological Tests
1
2009
927
0.020
Why?
Brain
1
2016
2371
0.010
Why?
Age Factors
1
2011
2894
0.010
Why?
Alzheimer Disease
1
2009
442
0.010
Why?
Magnetic Resonance Imaging
1
2009
3044
0.010
Why?
Kiser's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)